 |
Etanercept
Product Approval Information - Licensing Action
Proper name: Etanercept
Tradename: Enbrel
Manufacturer: Immunex Corp, Seattle, WA, License #1132
Expanded Indication: Reducing the signs and symptoms and delaying structural damage in patients with moderately to severely active rheumatoid arthritis, including those who have not previously failed treatment with DMARD
Approval Date: 6/6/2000
Type of submission: Biologics license supplement
Approval Letter (PDF),
(Text)
Label (PDF),
(Text)
Last Updated: 3/17/2001
 Back
to Top 
Back to Index
Updated: September 25, 2003 |
|
